Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07542184
NA

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama

Sponsor: Nanochon, Inc.

View on ClinicalTrials.gov

Summary

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Official title: A First in Human (FIH) Early Feasibility Study (EFS) to Evaluate the Safety and Performance of the Nanochon Chondrograft™ Implant for Re-surfacing of Cartilage Lesions

Key Details

Gender

All

Age Range

22 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

5

Start Date

2026-07-30

Completion Date

2027-09

Last Updated

2026-08-21

Healthy Volunteers

No

Interventions

DEVICE

Nanochon Chondrograft

Mini arthrotomy or arthroscopic surgical implantation of Nanochon Chondrograft

Locations (1)

The Panama Clinic

Panama City, Provincia de Panamá, Panama